Evidence map›Paper›PMID 36684959›Full record

ArticleFrontiers in public health2022

Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey).

Nicole H T M Dukers-Muijrers, Ymke Evers, Veja Widdershoven, Udi Davidovich, Philippe C G Adam, Eline L M Op de Coul, Paul Zantkuijl, Amy Matser, Maria Prins, Henry J C de Vries and 13 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Risk perception and mpox vaccine acceptability among people living with HIV in northern Nigeria.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Nicole H T M Dukers-MuijrersDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.
Ymke EversDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.
Veja WiddershovenDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.
Udi DavidovichDepartment of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands.
Philippe C G AdamInstitute for Prevention and Social Research in Utrecht, Utrecht, Netherlands.
Eline L M Op de CoulEpidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Paul ZantkuijlSoa Aids Nederland, Amsterdam, Netherlands.
Amy MatserDepartment of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands.
Maria PrinsDepartment of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands.
Henry J C de VriesDepartment of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands.
Casper den HeijerDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.
Christian J P A HoebeDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.
Anne-Marie NiekampDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.
Francine SchneiderDepartment of Health Promotion, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands.
Juliana Reyes-UrueñaEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Roberto CrociEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Angelo D'AmbrosioEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Marc van der ValkAmsterdam University Medical Center (UMC) Location University of Amsterdam, Infectious Diseases, Amsterdam, Netherlands.
Dirk PosthouwerDepartment of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, Netherlands.
Robin AckensDepartment of Integrated Care, Maastricht University Medical Centre (MUMC+), Maastricht, Netherlands.
Henriette Ter WaarbeekDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands.
Teymur NooriEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Elske HoornenborgDepartment of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In the 2022 multicountry mpox (formerly named monkeypox) outbreak, several countries offered primary preventive vaccination (PPV) to people at higher risk for infection. We study vaccine acceptance and its determinants, to target and tailor public health (communication-) strategies in the context of limited vaccine supply in the Netherlands. Methods: Online survey in a convenience sample of gay, bisexual and other men who have sex with men, including transgender persons (22/07-05/09/2022, the Netherlands). We assessed determinants for being (un)willing to accept vaccination. We used multivariable multinominal regression and logistic regression analyses, calculating adjusted odds ratios (aOR) and 95 percent confidence-intervals. An open question asked for campaigning and procedural recommendations. Results: Of respondents, 81.5% ( Conclusion: In the public health response to the mpox outbreak, key is a broad and equitable access to information, and to low-threshold vaccination options for those at highest risk. Communication should be uniform and transparent and tailored to beliefs, and include other preventive options. Mpox vaccine willingness was high. Public health efforts may be strengthened in less urbanized areas and reach out to those who lack relevant (community) social network influences.

Indexed as

Mpox, MonkeypoxSexual and Gender MinoritiesSmallpox VaccineCommunicationHealth Knowledge, Attitudes, PracticeHomosexuality, MaleHumansMaleNetherlandsPatient Acceptance of Health CareSurveys and QuestionnairesVaccinationSmallpox VaccinecommunicationGBMSMlow urbanmpoxpreventionpublic healthsocial networkvaccination

Identifiers

PMID36684959
PMCPMC9850232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.